Hizentra Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage Patient Counseling Information MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

The solution is clear. The colour can vary from pale-yellow to light-brown.
1 ml contains: 200 mg of human plasma protein, of which at least 98% is IgG (20% solution).
The osmolality is approximately 380 mOsmol/kg.
Active substance: Human normal immunoglobulin for subcutaneous injection (SCIg).
Human plasma protein, of which at least 98% is immunoglobulin type G (IgG).
The approximate distribution of IgG subclasses is as follows: IgG₁ 69%, IgG₂ 26%, IgG₃ 3%, IgG₄ 2%.
The maximum immunoglobulin type A (IgA) content is 50 micrograms/ml.
Excipients/Inactive Ingredients: L-proline, Polysorbate 80, water for injections q.s. ad solutionem pro 1 ml.

human normal immunoglobulin

Manufacturer:

CSL Behring

Distributor:

DKSH